Enriching Clinical Trials with Patient Reported Outcomes: Best Practices, Potential Pitfalls and New Approaches
12:15 PM - 12:45 PM
Signant Health's Chief Medical Officer, Dr. Dawie Wessels, will be attending and presenting at the 13th Annual CMO Summit 360°—the largest gathering of biotech Chief Medical Officers. During this industry event, Dr. Wessels will share valuable insights on advancing clinical development strategies in today's evolving healthcare landscape.
Dawie’s deep expertise across multiple therapeutic areas, multinational development leadership, and experience in associated commercial growth support the expanding impact of the Signant Science and Medical team. With over twenty years of experience combining medicine and business, Dawie oversees Signant's scientific and operational strategies.
If you're attending the CMO Summit 360° and would like to schedule time to meet with Dr. Wessels to discuss his presentation or explore potential collaborations, please complete the meeting request form below. Don't miss this chance to engage with one of the leading medical officers in biotechnology.